Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Enovis

13 Top Stocks With Huge Upside Potential To Buy Now

Top stock picks for long-term growth in 2025 focus on tech, energy, biotech and retail leaders with strong analyst buy ratings and high upside potential.

Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.

Enovis Hits Another 52-Week Low. Here’s Why It’s a Contrarian Buy.

The orthopedic medical device company hit its 41st 52-week low. The stock looks unnecessarily beaten down, off 41% over the past 12 months and 62% from its all-time high in November 2021, making it a contrarian buy.

Corporate leaders are facing disruptive threats on multiple fronts

Corporate leaders are facing disruptive threats on multiple fronts

C-suite leaders from Alliance Entertainment, 1-800-Flowers.com, BCG, Deepwatch, and other companies discuss how they are managing challenges to their businesses.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: Enovis Q1 Earnings

Recap: Enovis Q1 Earnings

Enovis (NYSE:ENOV) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings Enovis beat estimated earnings by 5.71%, reporting an EPS of $0.37 versus an estimate of $0.35.

People

165,647 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play